This site uses cookies to store information on your computer. Learn more x

DSM in Medical

DSM in the news 2016

News articles 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2007

Development of radiopaque UHMWPE. From idea to 510K approval

Sep 2016 - Chris Arts and colleagues at Maastricht University Medical Centre (Maastricht, the Netherlands) have developed and tested innovative radiopaque ultra-high molecular weight polyethylene (UHWMPE) wires for the treatment of early onset scoliosis. Intended to eliminate revision surgeries associated with treatment of the condition, Arts et al believe that adoption of the technology could drastically reduce costs for institutions, and lessen the psychosocial burden of multiple surgeries on patients. Their project is part of a collaboration between private industry, the government of the Netherlands, and a number of Dutch universities. In this special feature for Spinal News International, they describe the process of developing the technology, the journey to US Food and Drug Administration (FDA) 510(k) approval, and their hopes for the future adoption of UHWMPE cables. More>


State of (Implant) Affairs

May 2016 - Implant manufacturing, at the global scale, is growing at an annual rate of 3 to 5 percent. Even though there are tantalizing possibilities with disruptive technologies such as additive manufacturing and 3D printing (especially as products become smaller, more complex, and costly), many OEMs still feel more comfortable staying with proven and validated processes and materials. The challenge then becomes finding new ways to improve efficiency and save time and money. More>


Svelte Medical Systems Announces European Launch of SLENDER IDS™

Jan 2016 - Svelte Medical Systems, Inc. today announced the commercial launch of the SLENDER Sirolimus-Eluting Coronary Stent-On-A-Wire Integrated Delivery System (IDS) to select accounts in Europe specializing in TRI. The first advance in stent delivery since the rapid-exchange catheter, SLENDER IDS is the world’s lowest profile drug-eluting stent (DES), designed to reduce the catheter size and steps necessary to perform percutaneous coronary intervention (PCI). …DISCREET™ drug coating, applied to a highly conformable cobalt chrome stent, is composed of the well-studied drug sirolimus and a natural, amino acid-based polyesteramide (PEA) bioresorbable drug carrier proprietary to DSM Biomedical, a global leader in biomaterials science and regenerative medicine. More>